STABLON

This brand name is authorized in Austria, Brazil, France, Hong Kong, Malta, Singapore, Tunisia, Turkey

Active ingredients

The drug STABLON contains one active pharmaceutical ingredient (API):

1 Tianeptine UNII YG0E19592I - TIANEPTINE SODIUM

Tianeptine is an antidepressant. In man, tianeptine is characterised by marked action on somatic complaints, especially gastrointestinal complaints related to anxiety and mood disturbances. Moreover, tianeptine has no effect on sleep and alertness nor on the cholinergic system (no anticholinergic symptoms). Read about Tianeptine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
STABLON Coated tablet	Medicines Authority (MT)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AX14	Tianeptine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 531301301117319, 531301302113317, 531318010008703, 531318010008803
Country: FR	Base de données publique des médicaments	Identifier(s): 65411280
Country: HK	Department of Health Drug Office	Identifier(s): 51215
Country: MT	Medicines Authority	Identifier(s): MA066/01201
Country: SG	Health Sciences Authority	Identifier(s): 11182P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6353072
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699552090236